These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 843188)

  • 61. Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance.
    Preston KL; Umbricht A; Epstein DH
    Arch Gen Psychiatry; 2000 Apr; 57(4):395-404. PubMed ID: 10768702
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The SAODAP cooperative studies of LAAM: unblinded comparison with methadone.
    Klett CJ
    NIDA Res Monogr; 1978; (19):271-6. PubMed ID: 106292
    [No Abstract]   [Full Text] [Related]  

  • 63. Clonidine and naltrexone. A safe, effective, and rapid treatment of abrupt withdrawal from methadone therapy.
    Charney DS; Riordan CE; Kleber HD; Murburg M; Braverman P; Sternberg DE; Heninger GR; Redmond DE
    Arch Gen Psychiatry; 1982 Nov; 39(11):1327-32. PubMed ID: 7138234
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Editorial: Methadone maintenance.
    Lancet; 1975 Jan; 1(7900):208-9. PubMed ID: 47433
    [No Abstract]   [Full Text] [Related]  

  • 65. Abstinence fear in methadone maintenance withdrawal: a possible obstacle for getting off methadone.
    Eklund C; Hiltunen AJ; Melin L; Borg S
    Subst Use Misuse; 1997 May; 32(6):779-92. PubMed ID: 9178443
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Methadone dose and heroin use during maintenance treatment.
    Caplehorn JR; Bell J; Kleinbaum DG; Gebski VJ
    Addiction; 1993 Jan; 88(1):119-24. PubMed ID: 8448501
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Use of cocaine to prevent opiate withdrawal.
    Rosen MI; Wallace EA; Sullivan MC; Stine S; Kosten TR
    Am J Psychiatry; 1992 Nov; 149(11):1609. PubMed ID: 1415835
    [No Abstract]   [Full Text] [Related]  

  • 68. Rapid detoxification from opioid dependence under general anaesthesia versus standard methadone tapering: abstinence rates and withdrawal distress experiences.
    Krabbe PF; Koning JP; Heinen N; Laheij RJ; van Cauter RM; De Jong CA
    Addict Biol; 2003 Sep; 8(3):351-8. PubMed ID: 13129838
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Case report of barbiturate-induced enhancement of methadone metabolism and withdrawal syndrome.
    Liu SJ; Wang RI
    Am J Psychiatry; 1984 Oct; 141(10):1287-8. PubMed ID: 6486271
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population.
    Poling J; Oliveto A; Petry N; Sofuoglu M; Gonsai K; Gonzalez G; Martell B; Kosten TR
    Arch Gen Psychiatry; 2006 Feb; 63(2):219-28. PubMed ID: 16461866
    [TBL] [Abstract][Full Text] [Related]  

  • 71. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans.
    Donny EC; Walsh SL; Bigelow GE; Eissenberg T; Stitzer ML
    Psychopharmacology (Berl); 2002 May; 161(2):202-12. PubMed ID: 11981600
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Detoxification in withdrawal state in methadone maintenance patients].
    Sivolap I; Savchenkov VA; Aksel'rod BA; Kubarev DA; Chichenkov TO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(11):33-7. PubMed ID: 14681963
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Methadone maintenance programs.
    Berger H
    Postgrad Med; 1973 Oct; 54(4):165-6. PubMed ID: 4729171
    [No Abstract]   [Full Text] [Related]  

  • 74. Methadone maintenance treatment of narcotic addiction: a unit of medical care based on over 50,000 patient treatment years.
    Cushman P; Trussell R; Gollance H; Newman R; Bihari B
    Am J Drug Alcohol Abuse; 1976; 3(2):221-33. PubMed ID: 1032737
    [TBL] [Abstract][Full Text] [Related]  

  • 75. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
    Bloor M; McIntosh J; McKeganey N; Robertson M
    Public Health; 2008 Oct; 122(10):1013-9. PubMed ID: 18490036
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Urinary cyclic AMP excretion by methadone subjects during gradual and acute withdrawal.
    De Leon-Jones FA; Pandey GN; Davis JM; Garver DL; Inwang EE
    Psychopharmacology (Berl); 1977 Aug; 54(1):17-20. PubMed ID: 198838
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The relationship between age and-or negative experiences and success on a methadone maintenance program.
    Henchy T; Eckerson B; Paez JL
    Int J Addict; 1974; 9(2):221-7. PubMed ID: 4430520
    [No Abstract]   [Full Text] [Related]  

  • 78. Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials.
    Grabowski J; Rhoades H; Stotts A; Cowan K; Kopecky C; Dougherty A; Moeller FG; Hassan S; Schmitz J
    Neuropsychopharmacology; 2004 May; 29(5):969-81. PubMed ID: 15039761
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Contingent methadone delivery: effects on illicit-opiate use.
    Higgins ST; Stitzer ML; Bigelow GE; Liebson IA
    Drug Alcohol Depend; 1986 Jul; 17(4):311-22. PubMed ID: 3757767
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A study of some failures in methadone treatment.
    Perkins ME; Bloch HI
    Am J Psychiatry; 1971 Jul; 128(1):47-51. PubMed ID: 5155620
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.